Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case Series
Open Access
- 1 November 2020
- journal article
- letter
- Published by The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al in Allergy, Asthma & Immunology Research
- Vol. 12 (6), 1063-1065
- https://doi.org/10.4168/aair.2020.12.6.1063
Abstract
Seok SH, et al. Allergy Asthma Immunol Res. 2020 Nov;12(6):1063-1065. https://doi.org/10.4168/aair.2020.12.6.1063This publication has 7 references indexed in Scilit:
- Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case seriesBritish Journal of Dermatology, 2019
- Dupilumab facial redness: Positive effect of itraconazoleJAAD Case Reports, 2019
- The Skin Commensal Yeast Malassezia Triggers a Type 17 Response that Coordinates Anti-fungal Immunity and Exacerbates Skin InflammationCell Host & Microbe, 2019
- Dupilumab side effect in a patient with atopic dermatitis: a case report studyBiologics: Targets and Therapy, 2019
- Drug-induced phototoxicity: A systematic reviewJournal of the American Academy of Dermatology, 2018
- Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?British Journal of Dermatology, 2018
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic DermatitisNew England Journal of Medicine, 2014